Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03579680 · ClinicalTrials.gov registry record · NA
De-implementation of Low Value Castration for Men With Prostate Cancer
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT03579680 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 60 participants.
The verdict
NCT03579680, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This study will use a theory-based, mixed methods approach to identify, tailor and pilot two different de-implementation strategies that vary widely in delivery, impact, and expected results for reducing low value androgen deprivation therapy (ADT) use in preparation for a randomized comparative effectiveness trial comparing two tailored deimplementation strategies to reduce chemical castration as localized prostate cancer treatment and treatment for non-metastatic biochemical recurrence with low PSA levels.
Interventions
- BEHAVIORAL ADT ORDER CHECK ATTESTATION (OR)
- BEHAVIORAL PROVIDER SCRIPT (SC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2018-08-22 |
| Est. Completion | 2023-04-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03579680
The ClinicalTrials.gov registry entry for NCT03579680 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ADT ORDER CHECK ATTESTATION (OR) is the first listed.
NCT03579680 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03579680 about?
NCT03579680 is a clinical study titled "De-implementation of Low Value Castration for Men With Prostate Cancer". This study will use a theory-based, mixed methods approach to identify, tailor and pilot two different de-implementation strategies that vary widely in delivery, impact, and expected results for reducing low value androgen deprivation therapy (ADT) use in preparation for a randomized comparative eff...
What is the current status of trial NCT03579680?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2018-08-22. Estimated completion is 2023-04-06.
What interventions are being tested in trial NCT03579680?
The interventions under investigation include: ADT ORDER CHECK ATTESTATION (OR) (BEHAVIORAL), PROVIDER SCRIPT (SC) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03579680?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.